Dr. Berglund received his BS and MS from the University of N.H. and Boston University School of Medicine, respectively, and his PhD in biochemistry from Goethe University, Germany. He was a researcher at Sanofi‐Aventis, a USPTO registered patent agent, Medical Strategy Director at H4B Chelsea, a global healthcare communications consultancy, business development and strategy at Kyorin Pharmaceuticals, and CEO of Vaxiva KK, a Tokyo vaccine company.

Mr. Nelson graduated from Cornell University and received his J.D. from New York University School of Law. Previously, he was CFO & GC of an early stage healthcare company, an analyst at Barclays Capital and ING, an investment banker at CIBC World Markets and practiced law at Willkie Farr & Gallagher and Dewey Ballantine. Mr. Nelson is managing director and head of healthcare at Westwood Capital, LLC and president of Thea Capital Management, LLC.

Dr. Reisacher graduated from Cornell University and received his medical degree from Mount Sinai School of Medicine with distinction in research. His clinical expertise lies in the diagnosis and management of airborne and food allergies in adults and children. Dr. Reisacher is a General Otolaryngologist and Otolaryngic Allergist on the fulltime faculty of Weill Cornell Medical College, where he is Associate Professor and the Director of Allergy.